No-Competition Drugs Stir Controversy
13th Nov 2006, 20:37 GMT
By Diedtra Henderson, The Boston Globe Nov. 13--WASHINGTON -- Barr Pharmaceuticals Inc. has finally begun to ship its morning-after pill labeled for over-the-counter sales, but not without raising new questions about how the federal government has handled the drug.
No-Competition Drugs Stir Controversy related news:
- No-competition drugs stir controversy — Boston Globe -- Business News
- Controversy over Weisz 'drinking during pregnancy' comments — BreakingNews.ie - Entertainment
- NCC Calls for 'Dialogue of Civilizations' over Cartoon Controversy — The Christian Post RSS Feed
- Wal-Mart's the best Rx for Dems' drug problem — New York Daily News Online -- News & Views Columnists
- Pair held after drugs raid — BreakingNews.ie - Ireland
- Blanchardstown drugs strategy launched — The Irish Times' Irish Top Stories
- Compensation for robber denied drugs 'laughable' — the Mail online | News
- Ex-addicts defend jail drugs payouts — Telegraph News | UK News
- Controversy surrounds failed test drug results — Financial news of the day - CNNMoney.com
- Officers arrest 33 in drugs raids — BBC News | Latest Published Stories | World Edition
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry